 2. Primary breast cancers must be human epidermal growth factor receptor HER2 overexpressing 2 or 3, or both, as determined by immunohistochemistry IHC, and estrogen receptor ER positive. Primary breast cancers must be of clinical andor radiologic size 4 cm, with or without gross metastatic disease according to the International Union against Cancer UICC modified World Health Organization WHO criteria. 